ALRN-6924 vs Conantokin-G

Head-to-head comparison of ALRN-6924 (ALRN-6924 dual MDM2/MDMX stapled p53 mimetic peptide) and Conantokin-G (Conantokin-G from Conus geographus venom) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyALRN-6924Conantokin-G
CategoryExperimentalExperimental
Full NameALRN-6924 dual MDM2/MDMX stapled p53 mimetic peptideConantokin-G from Conus geographus venom
Molecular WeightN/A2,150 Da
Half-LifeHours to days depending on formulationMinutes to hours
Amino AcidsN/A17
Typical DoseVaries by clinical protocol0.1-10 nmol intrathecal|10-1000 nM in vitro|single-dose rodent studies
RouteIntravenous/SubcutaneousIntrathecal
Purity≥98%≥98%
Studies Count4095
Research StatusClinicalPre-clinical

ALRN-6924 Benefits

  • p53 reactivation
  • dual MDM2/MDMX inhibition
  • protease resistance
  • tumor cell apoptosis

Conantokin-G Benefits

  • NMDA receptor antagonism
  • seizure-model research
  • excitatory neurotransmission mapping
  • pain-mechanism studies

ALRN-6924 Dosing

Clinical trial protocol dosing|Intermittent administration|Research-only escalation

Conantokin-G Dosing

Intrathecal administration in seizure/pain models|NMDA receptor assays|In vitro excitation studies

ALRN-6924 Side Effects

  • nausea
  • fatigue
  • myelosuppression

Conantokin-G Side Effects

  • Sedation or dizziness in animals
  • motor effects at high exposure
  • off-target NMDA modulation

Research Overview

ALRN-6924

ALRN-6924 is one of the best-known stapled peptide therapeutics and has advanced into human oncology studies. Literature shows that hydrocarbon stapling can improve target affinity, serum stability, and cellular activity for this p53-mimetic scaffold.

Conantokin-G

Research has shown conantokin-G can suppress NMDA-mediated responses in a sequence- and modification-dependent manner. It remains a classic marine peptide tool for probing glutamatergic signaling and analgesia-related pathways.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

ALRN-6924 stacks with:

venetoclaxcisplatindoxorubicin

Conantokin-G stacks with:

ketaminememantinelamotrigine
stapled-peptidep53mdm2mdmxoncologycone-snailvenom-peptidenmda-antagonistneuroscience